Stockscreener 앱 받기
9.69
1.82%
-0.18
시장 영업 전:
9.79
0.10
+1.03%
Immunome Inc 주식(IMNM)의 최신 뉴스
Immunome Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Research Analysts Offer Predictions for Immunome Q3 Earnings - Defense World
What recovery options are there for Immunome Inc.5-Year Price Trend Summary and Analysis - Newser
Will Immunome Inc. stock recover after recent dropWeekly Breakout Forecast with Entry Zones - Newser
Will Immunome Inc. bounce back from current supportWeekly Price Target Forecast and Alerts - Newser
What makes Immunome Inc. stock attractive to long term investorsLong Term Stock Planner with Safety Checks - Newser
Immunome, Inc. (NASDAQ:IMNM) Revenue Estimates Upgraded by 73% - AInvest
Growth Investors: Industry Analysts Just Upgraded Their Immunome, Inc. (NASDAQ:IMNM) Revenue Forecasts By 73% - Yahoo Finance
How to forecast Immunome Inc. trends using time seriesDaily Trade Monitor with Pattern Alerts - Newser
Immunome 2025 Q2 Earnings Wider Net Loss Despite Revenue Surge - AInvest
New Product Launches: Will They Boost Immunome Inc. Stock in 2025Growth Focused Entry Plan Suggestions Issued - beatles.ru
JP Morgan Lowers Price Target for Immunome (IMNM) While Maintain - GuruFocus
Immunome 2025 Q2 Earnings Narrowed EPS Loss, 69.8% Revenue Growth - AInvest
What’s next for Immunome Inc. stock priceFree Secure Return Focused Investment Plan - Newser
Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update - BioSpace
Immunome Advances Cancer Therapy Pipeline Amid Financial Loss - TipRanks
Does Immunome Inc. qualify in momentum factor screeningFree Triple Return Setup with Risk Control - Newser
Immunome earnings beat by $0.12, revenue topped estimates - Investing.com Canada
Immunome’s Promising Clinical Progress and Strong Financial Position Justify Buy Rating - TipRanks
Immunome Q2 Earnings: Revenue $4.01M, Consensus $1.02M; Expects Cash to Fund Operations into 2027 - AInvest
Immunome, Inc. (IMNM) Reports Q2 Loss, Beats Revenue Estimates - Yahoo Finance
Immunome Reports Second Quarter 2025 Financial Results and Provi - GuruFocus
Detecting price anomalies in Immunome Inc. with AIFree Weekly Potential Breakout Stock List - Newser
How Immunome Inc. stock performs during market volatilityFree Momentum Based Equity Trading Plan - Newser
Can Immunome Inc. rally from current levelsStock Entry Point Planner with Volume Spike - Newser
Will Immunome Inc. continue its uptrendStock Market Trend and Pattern Analysis - Newser
What to do if you’re stuck in Immunome Inc.Real Stock Picks With Setup Verification - Newser
What earnings revisions data tells us about Immunome Inc.Trading Volume Spike and Reversal Analysis - Newser
What momentum shifts mean for Immunome Inc.Trade Flow Monitor with Volume Tracker - Newser
Will Immunome Inc. Stock Benefit from AI and Green Energy TrendsLow Risk High Confidence Watchlist Builder - Newser
What institutional investors are buying Immunome Inc. stockAchieve rapid portfolio growth with smart picks - Jammu Links News
How does Immunome Inc. compare to its industry peersCapitalize on stocks with high profit margins - Jammu Links News
What are Immunome Inc. company’s key revenue driversCapitalize on emerging industry trends - Jammu Links News
What is the risk reward ratio of investing in Immunome Inc. stockOutstanding capital returns - Jammu Links News
Is it the right time to buy Immunome Inc. stockInvest confidently with actionable market data - Jammu Links News
When is Immunome Inc. stock expected to show significant growthMaximize returns with effective portfolio management - Jammu Links News
Is Immunome Inc. stock overvalued or undervaluedRealize exceptional returns through smart trading - Jammu Links News
Immunome Inc. Stock Analysis and ForecastUnlock expert market analysis instantly - Jammu Links News
What is the dividend policy of Immunome Inc. stockBuild wealth faster with high-performing stocks - Jammu Links News
Why is Immunome Inc. stock attracting strong analyst attentionTriple-digit return opportunities - Jammu Links News
Why Immunome Inc. stock attracts strong analyst attentionReal Time Stock Movement Analysis Indicates Breakout - beatles.ru
Immunome Grants Inducement Awards to New Employees Under Nasdaq Rules, Prices Stock Options at $10.59. - AInvest
Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
0.24%
3.39%
자본화:
|
볼륨(24시간):